{"name":"Ophthotech Corporation","slug":"ophthotech-corporation","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Zimura","genericName":"Zimura","slug":"zimura","indication":"Other","status":"discontinued"}]}],"pipeline":[{"name":"Zimura","genericName":"Zimura","slug":"zimura","phase":"discontinued","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxOTHNDR2RoWGUwU3lJeHRocVBKaW5WQ09zM2xwWEQzS1JTMndGcFhUcDV0OUpsNTBycEgwVUY3YUJjZ01EOEJJOXdzaER6RF9yQncwc2txQmlGUnktdXBzNXFWVFhpREthbmlabF9vd0JCYTdyYkJnTUxaNkFsbl9tOGt0Qko4TWRmbjh0QnhQa1AtVkRESktTR2lR?oc=5","date":"2026-04-08","type":"pipeline","source":"openPR.com","summary":"Emerging Growth Patterns Driving Expansion in the Anterior Uveitis Market - openPR.com","headline":"Emerging Growth Patterns Driving Expansion in the Anterior Uveitis Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxNZ3M2UVJDSERLYUlKQ1MzdVpmZ1k0aGVoYnpfVlZORnpSM0h3ODJWandhOUJrNDJmMDBIUm5WaURPb01VTnU4NzNXcXE1NWk3Vk5MZjRUSDV0R0VGcFFVSFVyRHkzSGYzUWE1R2pIMWh1elRINk1vbnVIRDdsUWc2eXFZQmk?oc=5","date":"2025-05-02","type":"pipeline","source":"American Academy of Ophthalmology","summary":"Corporate and Institutional Support - American Academy of Ophthalmology","headline":"Corporate and Institutional Support","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQcVYza2x0Qy1JdUZ4U0hUYVNCOW1NWW43YWV6elpjUE8yZ0F0WnRBNlVaWFgzUVYtQXFOYUFmNmJMQUxHWWN3Mkp6SGRUQUpTdmhHbnhPancwQU9VZDROT2JINmhmNU1qMjlsZDJ3aWpDYl9iWW1qZTB6dmE3SHkzbHBPQjFlcXdfcEdzRkREb1paZw?oc=5","date":"2024-05-29","type":"pipeline","source":"BioWorld News","summary":"Merck paying $1.3B up front for 3-year-old Eyebio - BioWorld News","headline":"Merck paying $1.3B up front for 3-year-old Eyebio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNVXZkaDdIbElRbEkzWVlvb1lnXzhlaF9yNXRFVDhPZG9WSVpaT09mVHhqWE9TRXJRd3JrYzJzUjBBVVVVMTNZb3BXdFJnSWtBb0pMZUdIWEFZX2R2SWI0Ukl2bm5GTERGd284VWZZRmhpSXJFak1tSk10dGRpUGZsLXpFaGx2cUlMX2Z5eGZoWkFKZw?oc=5","date":"2023-05-01","type":"deal","source":"Reuters","summary":"Astellas Pharma buys Iveric Bio for $5.9 billion - Reuters","headline":"Astellas Pharma buys Iveric Bio for $5.9 billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxOY18taV80dEpWX3RQSUFWQnQ4ZFQzTnNydmpOZndqbEVWLUtVcWpKeVlzWWRURzIyT1pTZ0pmX1Q3U1VqdTR3Ty16SFh1RmlpRzRZV0hzNmUtYjVoN281cjBjVmZiQ1BvMmJVYmJkR3lyTzNsSU9OaWpYeUpHNU5ub2NKSmhNaGczWGVr?oc=5","date":"2019-01-24","type":"pipeline","source":"BioSpace","summary":"Vertex Fires COO for Violations of Company Code of Conduct - BioSpace","headline":"Vertex Fires COO for Violations of Company Code of Conduct","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxNNlY4dXdUd0V6N3ZkQVZQZ3BURUJXZ1ZfMFU2TkhZWW9BbHZnZ0NVZEhVVDJNVlNTUVdYWk8ySTlUY0Zsd1VRdEg4VzZxWnJfTEg5bXlzbks2VjRLaDl1c0xNcm1zS2pQRlN5LTNCR3FNYlQwbE40Qm9ZUzZDYnpPVThUcHkyUUx6eUlnTE9lOG00UHVqX2FjSldJUy1ERGxCVEg4SldfLW1vVzVXd2E1d2ZzNUdWaUxMYmw4?oc=5","date":"2019-01-10","type":"trial","source":"Clinical Leader","summary":"Significant Number Of Drugs Will Launch For The Treatment Of Age-Related Macular Degeneration By 2026 Says GlobalData - Clinical Leader","headline":"Significant Number Of Drugs Will Launch For The Treatment Of Age-Related Macular Degeneration By 2026 Says GlobalData","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxOSm5jbzBLU1dsRjdpbVlqOWlURXByeW1GbUNWS0JmZlRZUlg0ZHN2elZKaXd0dnlfdWZpaWxDZURkdTdjczg3cGdOdWpVMGlwSnhKaWFQSExyUG1KSG9UbUgwVUVnTnhwcXJfb0pFQ1V0Vlh3WkhsOFJFTjAzLWVIWFJCZ3JCQVpSWHpad3BpVmxSSlpUWmc?oc=5","date":"2017-08-14","type":"trial","source":"drugdeliverybusiness.com","summary":"Ophthotech eye-drug trial fails to meet primary endpoint - drugdeliverybusiness.com","headline":"Ophthotech eye-drug trial fails to meet primary endpoint","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQcnA5SV9MbHZpTTNicHZRemdYY0dhVEFVNW5CZmZTXzBBcFBoTXpwZU1HQnhkemZYQmJQbnlGd3dYNmIzam1VMm1oVGdKMkhDUnhzQU9Cc3BwTFpxcGlTaHFCakJVVy1fc0oxUDBvc1NwbzFYbTg5dHk3VHdXTjRaVUhhcU1HTW5XSjMzYVJRQdIBlAFBVV95cUxPX194cmdCVW5OX0ZQalJyQTlYYi05Tm9SU2JJMkhMbnpOZ2g3bnIzeC1aY3VSMXB3OXRkZnNEbnQ2N25YczhrSnBjSEFWQ3NxUnRrdnlmVVhWRkl1SDRuUEFySnNkdnJFNWY0MjlWWjBpYzA4dFlDNVlUbXZlc1U0Unk1bzZ6bmN6ajIzU1hOQ3d5aU5W?oc=5","date":"2016-09-30","type":"pipeline","source":"Fox Business","summary":"Here's Why Ophthotech Corporation Is Dropping Today - Fox Business","headline":"Here's Why Ophthotech Corporation Is Dropping Today","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxNeXI2TC0yNEF3RGp5ek1FOTNzdGhqX3lSQ2NjYzZhX2NoOHBLS1lNRWtNUDB0TTZxTjFNTkxQQlFXZEl5dDJBSVNpOWNIeE85MVM0S3RLVlFEYkV5ejN3eUNnWk1Yc1hFYWZyaUJ5MHB0dUtfTnc2aEZHdFh3bzJWbWhvbGw2cWxTQVNKck4tcTNxTFo4UWwtbDJfOUV6X3I1YV9NM0xITV9VVGVEV2JDOA?oc=5","date":"2016-01-04","type":"pipeline","source":"PMLiVE","summary":"Glenn Sblendorio to retire as president of The Medicines Company - PMLiVE","headline":"Glenn Sblendorio to retire as president of The Medicines Company","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"discontinued":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}